Abstract:Background: Balanced chromosomal aberrations, especially balanced translocations, can cause infertility, recurrent miscarriage or having chromosomally defective offspring. Preimplantation genetic testing for structural rearrangement (PGT-SR) has been widely implemented to improve the clinical outcomes by selecting euploid embryos for transfer, whereas embryos with balanced translocation karyotype were difficult to be distinguished by routine genetic techniques from those with a normal karyotype. Method: In this present study, we developed a clinically applicable method for reciprocal translocation carriers to reduce the risk of pregnancy loss. In the preclinical phase, we identified reciprocal translocation breakpoints in blood of translocation carriers by long-read Oxford Nanopore sequencing, followed by junction-spanning polymerase chain reaction (PCR) and Sanger sequencing. In the clinical phase of embryo diagnosis, aneuploidies and unbalanced translocations were screened by comprehensive chromosomal screening (CCS) with single nucleotide polymorphism (SNP) microarray, carrier embryos were diagnosed by junction-spanning PCR and family haplotype linkage analysis of the breakpoints region. Amniocentesis and cytogenetic analysis of fetuses in the second trimester were performed after embryo transfer to conform the results diagnosed by the presented method. Results: All the accurate reciprocal translocation breakpoints were effectively identified by Nanopore sequencing and confirmed by Sanger sequencing. Twelve embryos were biopsied and detected, the results of junction-spanning PCR and haplotype linkage analysis were consistent. In total, 12 biopsied blastocysts diagnosed to be euploid, in which 6 were aneuploid or unbalanced, three blastocysts were identified to be balanced translocation carriers and three to be normal karyotypes. Two euploid embryos were subsequently transferred back to patients and late prenatal karyotype analysis of amniotic fluid cells was performed. The outcomes diagnosed by the current approach were totally consistent with the fetal karyotypes. Conclusions: In summary, these investigations in our study illustrated that chromosomal reciprocal translocations in embryos can be accurately diagnosed. Long-read Nanopore sequencing and breakpoint analysis contributes to precisely evaluate the genetic risk of disrupted genes, and provides a way of selecting embryos with normal karyotype, especially for couples those without a reference.

Evaluation of Preimplantation Genetic Testing Based on Next-Generation Sequencing for Balanced Reciprocal Translocation Carriers.

Application of Preimplantation Genetic Testing for Aneuploidies with Next-Generation Sequencing in Women with Advanced Maternal Age

Using SNP array to identify aneuploidy and segmental imbalance in translocation carriers.

Preimplantation genetic testing for structural rearrangement based on low-coverage next-generation sequencing accurately discriminates between normal and carrier embryos for patients with translocations

Clinical Application of Next-Generation Sequencing in Preimplantation Genetic Diagnosis Cycles for Robertsonian and Reciprocal Translocations

Chromosomal Analysis for Embryos from Balanced Chromosomal Rearrangement Carriers Using Next Generation Sequencing

Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing

Identifying Balanced Chromosomal Translocations in Human Embryos by Oxford Nanopore Sequencing and Breakpoints Region Analysis

Preferential Selection and Transfer of Euploid Noncarrier Embryos in Preimplantation Genetic Diagnosis Cycles for Reciprocal Translocations.

A Rapid NGS-Based Preimplantation Genetic Testing for Chromosomal Abnormalities in Day-3 Blastomere Biopsy Allows Embryo Transfer Within the Same Treatment Cycle.

Successful Birth after Preimplantation Genetic Testing for a Couple with Two Different Reciprocal Translocations and Review of the Literature

Comprehensive preimplantation genetic testing for balanced insertional translocation carriers

Preimplantation Genetic Testing Results of Blastocysts from 12 Non-Robertsonian Translocation Carriers with Chromosome Fusion and Comparison with Robertsonian Translocation Carriers

Reproductive Risks and Preimplantation Genetic Testing Intervention for X-autosome Translocation Carriers

Feasibility Study of Using Unbalanced Embryos As a Reference to Distinguish Euploid Carrier from Noncarrier Embryos by Single Nucleotide Polymorphism Array for Reciprocal Translocations.

Preimplantation genetic testing for complex chromosomal rearrangements: clinical outcomes and potential risk factors

Pregnancy Outcomes of Reciprocal Translocation Carriers with Two or More Unfavorable Pregnancy Histories: Before and after Preimplantation Genetic Testing

Reciprocal Translocation Carrier Diagnosis in Preimplantation Human Embryos

Factors affecting the reproductive outcome in reciprocal translocation carriers undergoing preimplantation genetic testing for structural rearrangements (PGTSR)

Number of blastocysts biopsied as a predictive indicator to obtain at least one normal/balanced embryo following preimplantation genetic diagnosis with single nucleotide polymorphism microarray in translocation cases

Chromosomal Concordance Between Babies Produced by the Preimplantation Genetic Testing for Aneuploidies and Trophectoderm Biopsies: A Prospective Observational Study.